HYPERTENSION--TRAINING-INDUCED INCREASE IN WORK CAPACITY
高血压——训练引起的工作能力的提高
基本信息
- 批准号:2221343
- 负责人:
- 金额:$ 13.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-05-01 至 1998-04-30
- 项目状态:已结题
- 来源:
- 关键词:caffeine calcium channel calcium flux disease /disorder model exercise fluorescence microscopy heart cell heart contraction heart metabolism immunocytochemistry laboratory rabbit laboratory rat myocardium radionuclides renal hypertension sodium channel training ventricular hypertrophy video microscopy
项目摘要
Cellular Ca2+ regulation is altered in hearts having undergone left
ventricular (LV) hypertrophy secondary to renovascular hypertension
(RvHtn). In single paced LV myocytes, RvHtn elicits reductions in the
amplitude of the cytosolic [Ca2+] ([Ca2+]c) transient and the rate at which
[Ca2+]c returns to basal levels. These alterations in [Ca2+]c dynamics
occur concomitantly with a reduced myocyte contractile response and slowed
myocyte relaxation. At the whole organ level, Ca2+-dependent LV
contractile autoregulation is compromised by RvHtn. These intrinsic
functional changes in global and single cell function appear to occur
concomitantly with alterations in the expression and/or function of several
sarcolemmal (SL) and sarcoplasmic reticular (SR) Ca2+ regulatory proteins.
Exercise training has been shown to prevent and/or reverse decrements in
LV contractile function that result from RvHtn and to elicit adaptive
responses at several Ca2+ regulatory loci. PRIMARY OBJECTIVES of this
proposal are to determine if endurance training (i) can restore normal
[Ca2+]c dynamics and contractile function to single LV myocytes isolated
from RvHtn rats. (ii) Steps will be taken to localize the cellular
processes that are responsible for altered myocyte [Ca2+]c dynamics in
RvHtn myocytes and (iii) to identify the influence of training on those
processes. to accomplish these objectives, RvHtn and LV hypertrophy will
be produced in male Fisher 344 rats using a Goldblatt, 2 kidney-1 clip
procedure. LV myocardium and single LV myocytes isolated from sedentary
normotensive (NSd), trained normotensive (NTr), sedentary hypertensive
(HSd), and trained hypertensive (HTr) rats will be studied. Morphology,
contractile function, and [Ca2+]c dynamics in NSd, NTr, HSd, and HTr
myocytes will be assessed using fluorescence and video microscopy. In the
LV myocyte studies, pacing and perfusion conditions will be altered to
differentially perturb cellular Ca2+ influx and efflux mechanisms; rapid
cooling contractures will be used to bioassay the amount of releasable Ca2+
that is in the SR. Caffeine contracture studies will be used to assess the
relative roles of SR Ca2+ uptake and Na+-Ca2+ exchange in relaxation in
intact myocytes. For the sake of interpretive relevance, studies of global
LV contractile function will be conducted in parallel to the single myocyte
experiments. Biochemical, pharmacological, and immunochemical techniques
will be used to assess the singular and combined effects of training and
RvHtn on the expression and/or function of key SL and SR Ca2+ and Na+
regulatory proteins; myocyte Ca2+ and Na+ regulation are intimately linked.
A better understanding of the Ca2+ regulatory changes that occur in
response to training and RvHtn, and the impact of these changes on single
myocyte and global LV function may prove useful in the development of
clinical strategies to prevent myocardial dysfunction associated with
hypertensive heart disease.
左心室心肌细胞内钙离子的调节发生改变
继发于肾血管性高血压的心室(LV)肥大
(RvHtn)。 在单次起搏的左心室肌细胞中,RvHtn可使心肌细胞内的
胞浆[Ca2 +]([Ca2 +] c)瞬变的幅度和
[Ca2+] c恢复到基础水平。 [Ca2 +] c动态的这些改变
与肌细胞收缩反应减少同时发生并减慢
肌细胞松弛 在整个器官水平,Ca 2+依赖性LV
收缩性自动调节受到RvHtn的损害。 这些内在
整体和单个细胞功能似乎发生了功能性变化
伴随着几个基因的表达和/或功能的改变,
肌膜(SL)和肌浆网(SR)Ca 2+调节蛋白。
运动训练已被证明可以防止和/或逆转
由RvHtn引起的LV收缩功能,
在几个Ca2+调节位点的反应。 这方面的主要成就
建议是确定耐力训练(i)是否可以恢复正常
[Ca2分离的单个LV肌细胞的+] c动力学和收缩功能
来自RvHtn大鼠。 (ii)我们将采取措施定位
过程,负责改变心肌细胞[Ca2 +] c动力学,
RvHtn肌细胞和(iii)确定训练对那些
流程. 为了实现这些目标,RvHtn和LV肥大将
使用Goldblatt,2肾-1夹在雄性Fisher 344大鼠中产生
procedure. 左心室心肌和单个左心室心肌细胞分离自久坐
血压正常(NSd)、训练血压正常(NTr)、久坐高血压
(HSd)和训练的高血压(HTr)大鼠进行研究。 形态学,
NSd、NTr、HSd和HTr的收缩功能和[Ca2 +] c动态
使用荧光和视频显微镜评估肌细胞。 在
LV肌细胞研究、起搏和灌注条件将改变,
差异干扰细胞Ca2+内流和外排机制;快速
冷却挛缩将用于生物测定可释放的Ca2+的量
咖啡因挛缩研究将用于评估
SR Ca~(2+)摄取和Na~+-Ca~(2+)交换在舒张中的相对作用
完整的肌细胞 为了解释的相关性,研究全球
LV收缩功能将与单个肌细胞平行进行
实验 生物化学、药理学和免疫化学技术
将用于评估培训的单一和综合效果,
RvHtn对关键SL和SR Ca 2+和Na+的表达和/或功能的影响
调节蛋白;肌细胞Ca 2+和Na+调节密切相关。
更好地理解在细胞内发生的Ca2+调节变化,
对训练和RvHtn的反应,以及这些变化对单个
心肌细胞和整体左心室功能可能被证明是有用的发展,
临床策略,以防止心肌功能障碍相关的
高血压性心脏病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Russell L Moore其他文献
Russell L Moore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Russell L Moore', 18)}}的其他基金
Exercise Training and Myocardial K-ATP Channel Function
运动训练与心肌K-ATP通道功能
- 批准号:
6875637 - 财政年份:2004
- 资助金额:
$ 13.73万 - 项目类别:
Exercise Training and Myocardial K-ATP Channel Function
运动训练与心肌K-ATP通道功能
- 批准号:
7052837 - 财政年份:2004
- 资助金额:
$ 13.73万 - 项目类别:
Exercise Training and Myocardial K-ATP Channel Function
运动训练与心肌K-ATP通道功能
- 批准号:
7211457 - 财政年份:2004
- 资助金额:
$ 13.73万 - 项目类别:
Exercise Training and Myocardial K-ATP Channel Function
运动训练与心肌K-ATP通道功能
- 批准号:
6731912 - 财政年份:2004
- 资助金额:
$ 13.73万 - 项目类别:
MYOCARDIAL ADAPTATIONS TO ADVANCE AGE AND EXERCISE
心肌对高龄和运动的适应
- 批准号:
6168849 - 财政年份:1999
- 资助金额:
$ 13.73万 - 项目类别:
MYOCARDIAL ADAPTATIONS TO ADVANCE AGE AND EXERCISE
心肌对高龄和运动的适应
- 批准号:
2859694 - 财政年份:1999
- 资助金额:
$ 13.73万 - 项目类别:
MYOCARDIAL ADAPTATIONS TO ADVANCE AGE AND EXERCISE
心肌对高龄和运动的适应
- 批准号:
6372083 - 财政年份:1999
- 资助金额:
$ 13.73万 - 项目类别:
AGING AND CARDIOCYTE MITOCHONDRIAL CA++ HANDLING IN SITU
衰老与心肌细胞线粒体 CA 原位处理
- 批准号:
2632622 - 财政年份:1998
- 资助金额:
$ 13.73万 - 项目类别:
HYPERTENSION--TRAINING-INDUCED INCREASE IN WORK CAPACITY
高血压——训练引起的工作能力的提高
- 批准号:
2221344 - 财政年份:1993
- 资助金额:
$ 13.73万 - 项目类别:
HYPERTENSION--TRAINING-INDUCED INCREASE IN WORK CAPACITY
高血压——训练引起的工作能力的提高
- 批准号:
2221345 - 财政年份:1993
- 资助金额:
$ 13.73万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 13.73万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 13.73万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 13.73万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 13.73万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 13.73万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 13.73万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 13.73万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 13.73万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 13.73万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 13.73万 - 项目类别:














{{item.name}}会员




